Discover
RYTM
Rhythm Pharmaceuticals, Inc.
110.41
2 x 81.69
2 x 141.60
bid
ask
-
0.62
0.56%
2 @ 04:00 PM
112.23 +1.82 (1.65%)
| Ytd | 3.15% | |
| 1y | 68.72% |
110.01
day range
114.58
64.65
52 week range
122.20
| Open | 111.07 | Prev Close | 111.03 | Low | 110.01 | High | 114.58 | Mkt Cap | 7.57B |
| Vol | 994.23K | Avg Vol | 792.73K | EPS | -3.12 | P/E | N/A | Forward P/E | -148.93 |
| Beta | 1.92 | Short Ratio | 12.80 | Inst. Own | 109.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 91.71 | 200-d Avg | 98.07 | 1yr Est | 139.47 |
| Income Statement | |||
| Total Revenue | 60.11M | ||
| Revenues (USD) | 60.11M | ||
| Cost of Revenue | 7.16M | ||
| Gross Profit | 52.96M | ||
| Operating Expenses | 105.32M | ||
| Research and Development Expense | 41.73M | ||
| Selling, General and Administrative Expense | 63.59M | ||
| Operating Income | -52.36M | ||
| Interest Expense | 4.58M | ||
| Income Tax Expense | 545.00K | ||
| Net Income | -55.64M | ||
| Net Income Common Stock | -56.74M | ||
| Net Income Common Stock (USD) | -56.74M | ||
| Consolidated Income | -55.64M | ||
| Earnings per Basic Share | -0.83 | ||
| Earnings per Basic Share (USD) | -0.83 | ||
| Earnings per Diluted Share | -0.83 | ||
| Earning Before Interest & Taxes (EBIT) | -50.51M | ||
| Earning Before Interest & Taxes (USD) | -50.51M | ||
| Preferred Dividends Income Statement Impact | 1.10M | ||
| Weighted Average Shares | 67.97M | ||
| Weighted Average Shares Diluted | 67.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.74M | ||
| Cash and Equivalents (USD) | 62.74M | ||
| Investments | 278.49M | ||
| Investments Current | 278.49M | ||
| Trade and Non-Trade Receivables | 34.19M | ||
| Current Assets | 430.09M | ||
| Property, Plant & Equipment Net | 4.00M | ||
| Total Assets | 442.32M | ||
| Debt Current | 676.00K | ||
| Total Debt | 3.84M | ||
| Current Liabilities | 103.20M | ||
| Debt Non-Current | 3.16M | ||
| Total Liabilities | 204.70M | ||
| Accumulated Retained Earnings (Deficit) | -1.41B | ||
| Accumulated Other Comprehensive Income | 444.00K | ||
| Shareholders Equity | 122.91M | ||
| Shareholders Equity (USD) | 122.91M | ||
| Assets Non-Current | 12.23M | ||
| Total Debt (USD) | 3.84M | ||
| Deferred Revenue | 48.00K | ||
| Goodwill and Intangible Assets | 5.11M | ||
| Inventory | 28.65M | ||
| Liabilities Non-Current | 101.50M | ||
| Trade and Non-Trade Payables | 12.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 252.00K | ||
| Net Cash Flow from Financing | -5.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.92M | ||
| Issuance (Purchase) of Equity Shares | 7.35M | ||
| Net Cash Flow from Investing | 57.05M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 57.05M | ||
| Net Cash Flow from Operations | -44.18M | ||
| Effect of Exchange Rate Changes on Cash | 448.00K | ||
| Share Based Compensation | 23.10M | ||